Does the Incremental Value of I-Metaiodobenzylguanidine SPECT/CT over Planar Imaging Justify the Increase in Radiation Exposure?

Overview

Journal Nucl Med Mol Imaging

Publisher Springer

Date 2021 Aug 23

PMID 34422127

Authors

Dorra Ben-Sellem

Naima Ben-Rejeb

Affiliations

Soon will be listed here.

Abstract

Purpose: Planar scintigraphy with I-radiolabeled metaiodobenzylguanidine (I-mIBG) is an important imaging modality to evaluate neuroblastoma. In recent years, Single Photon Emission Computed Tomography combined with Computed Tomography (SPECT/CT) has revolutionized nuclear medicine. Nevertheless, the addition of the CT has increased the patients' irradiation. We aimed to evaluate the incremental benefits of I-mIBG SPECT/CT over conventional planar imaging and to estimate the relative increase of radiation dose.

Methods: We retrospectively evaluated the added value of 56 SPECT/CT performed in 40 children in terms of better characterization of the lesion and its locoregional extension, better lymph node staging, detection of new lesions, and elimination of false positives by a paired comparison between the planar images and the SPECT/CT ones. Then, we calculated the percentage contribution of the additional radiation of the CT in this hybrid imagery.

Results: In 88% (49 out of 56) of the examinations, SPECT/CT provided additional information, which was crucial in 20% of the cases. It allowed a better characterization of the lesion and its locoregional extension in 44 cases, a better lymph node staging in 28 cases, the detection of 33 new lesions, and the elimination of 9 false positives. The CT effective dose was significantly lower than the SPECT one. The average additional radiation exposure due to CT was 12% (4-23%).

Conclusion: I-mIBG SPECT/CT has an undeniable added value that improves planar imaging interpretation and impacts patient management. These potential benefits would justify the low additional radiation induced by the CT.

References

Smith M, Seibel N, Altekruse S, Ries L, Melbert D, OLeary M . Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010; 28(15):2625-34. PMC: 2881732. DOI: 10.1200/JCO.2009.27.0421. View

Paiva F, do Carmo Santana P, Prata Mourao A . Evaluation of patient effective dose in a PET/CT test. Appl Radiat Isot. 2019; 145:137-141. DOI: 10.1016/j.apradiso.2018.12.024. View

Balwierz W, Wieczorek A, Klekawka T, Garus K, Bolek-Marzec K, Perek D . [Treatment results of children with neuroblastoma: report of Polish Pediatric Solid Tumor Group]. Przegl Lek. 2011; 67(6):387-92. View

Liu B, Servaes S, Zhuang H . SPECT/CT MIBG Imaging Is Crucial in the Follow-up of the Patients With High-Risk Neuroblastoma. Clin Nucl Med. 2018; 43(4):232-238. DOI: 10.1097/RLU.0000000000001984. View

Theerakulpisut D, Raruenrom Y, Wongsurawat N, Somboonporn C . Value of SPECT/CT in Diagnostic I-131 MIBG Scintigraphy in Patients with Neuroblastoma. Nucl Med Mol Imaging. 2018; 52(5):350-358. PMC: 6177351. DOI: 10.1007/s13139-018-0532-y. View

Piccardo A, Morana G, Puntoni M, Campora S, Sorrentino S, Zucchetta P . Diagnosis, Treatment Response, and Prognosis: The Role of F-DOPA PET/CT in Children Affected by Neuroblastoma in Comparison with I-mIBG Scan: The First Prospective Study. J Nucl Med. 2019; 61(3):367-374. DOI: 10.2967/jnumed.119.232553. View

Shahrokhi P, Emami-Ardekani A, Harsini S, Eftekhari M, Fard-Esfahani A, Fallahi B . Ga-DOTATATE PET/CT Compared with I-MIBG SPECT/CT in the Evaluation of Neural Crest Tumors. Asia Ocean J Nucl Med Biol. 2020; 8(1):8-17. PMC: 6994775. DOI: 10.22038/aojnmb.2019.41343.1280. View

Rozovsky K, Koplewitz B, Krausz Y, Revel-Vilk S, Weintraub M, Chisin R . Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma. AJR Am J Roentgenol. 2008; 190(4):1085-90. DOI: 10.2214/AJR.07.2107. View

Quinn B, Dauer Z, Pandit-Taskar N, Schoder H, Dauer L . Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates. BMC Med Imaging. 2016; 16(1):41. PMC: 4912712. DOI: 10.1186/s12880-016-0143-y. View

10.

Lonergan G, Schwab C, Suarez E, Carlson C . Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics. 2002; 22(4):911-34. DOI: 10.1148/radiographics.22.4.g02jl15911. View

11.

Law M, Ma W, Leung R, Li S, Wong K, Ho W . Evaluation of patient effective dose from sentinel lymph node lymphoscintigraphy in breast cancer: a phantom study with SPECT/CT and ICRP-103 recommendations. Eur J Radiol. 2012; 81(5):e717-20. DOI: 10.1016/j.ejrad.2012.01.035. View

12.

Frappaz D, Giammarile F, Thiesse P, Ranchere-Vince D, Louis D, Guibaud L . False positive MIBG scan. Med Pediatr Oncol. 1997; 29(6):589-92. DOI: 10.1002/(sici)1096-911x(199712)29:6<589::aid-mpo14>3.0.co;2-1. View

13.

Park J, Eggert A, Caron H . Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am. 2010; 24(1):65-86. DOI: 10.1016/j.hoc.2009.11.011. View

14.

Papaioannou G, McHugh K . Neuroblastoma in childhood: review and radiological findings. Cancer Imaging. 2005; 5:116-27. PMC: 1665241. DOI: 10.1102/1470-7330.2005.0104. View

15.

Melzer H, Coppenrath E, Schmid I, Albert M, von Schweinitz D, Tudball C . ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma. Eur J Nucl Med Mol Imaging. 2011; 38(9):1648-58. DOI: 10.1007/s00259-011-1843-8. View

16.

Meyer-Rochow G, Schembri G, Benn D, Sywak M, Delbridge L, Robinson B . The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma. Ann Surg Oncol. 2009; 17(2):392-400. DOI: 10.1245/s10434-009-0850-5. View

17.

Perwein T, Lackner H, Sovinz P, Benesch M, Schmidt S, Schwinger W . Survival and late effects in children with stage 4 neuroblastoma. Pediatr Blood Cancer. 2011; 57(4):629-35. DOI: 10.1002/pbc.23036. View

18.

Jaques Jr S, Tobes M, Sisson J . Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one. Cancer Res. 1987; 47(15):3920-8. View

19.

Bonnin F, Lumbroso J, Tenenbaum F, Hartmann O, Parmentier C . Refining interpretation of MIBG scans in children. J Nucl Med. 1994; 35(5):803-10. View

20.

Gasnier B, Roisin M, Scherman D, Coornaert S, Desplanches G, Henry J . Uptake of meta-iodobenzylguanidine by bovine chromaffin granule membranes. Mol Pharmacol. 1986; 29(3):275-80. View